1937day.year
South African medical researcher Max Theiler develops the yellow fever vaccine at the Rockefeller Foundation in New York City.
Max Theiler developed the first effective yellow fever vaccine at the Rockefeller Foundation, revolutionizing disease prevention.
His work laid the foundation for global immunization efforts.
In April 1937, virologist Max Theiler announced the creation of a live-attenuated yellow fever vaccine, known as the 17D strain, at the Rockefeller Foundation in New York City.
Theiler’s vaccine proved both safe and highly protective against the deadly virus in clinical trials and field use.
This breakthrough dramatically reduced yellow fever outbreaks in Africa and South America, saving countless lives.
Theiler’s work demonstrated the potential of live-attenuated vaccines and spurred advances in virology and immunology.
For his pioneering achievements, Max Theiler received the Nobel Prize in Physiology or Medicine in 1951.
1937
South African
Max Theiler
yellow fever
vaccine
Rockefeller Foundation
New York City